Identification and characterization of cellular factors involved in HCV entry

参与 HCV 进入的细胞因子的鉴定和表征

基本信息

  • 批准号:
    8463102
  • 负责人:
  • 金额:
    $ 51.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-12-15 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a competing renewal of a grant "Identification and characterization of cellular factors involved in HCV entry" first funded in 2006. Our laboratory has been studying the mechanisms of hepatitis C virus (HCV) gene expression and replication for over twenty years, but our understanding of viral entry was limited by inadequate study systems. We and others overcame this hurdle by developing the first platforms for studying HCV entry in vitro - HCV pseudoparticles (HCVpp) and the fully-infectious HCV cell culture system (HCVcc). With the advent of these new tools, we proposed to identify and characterize factors required for HCV uptake. A long- term goal of these studies was to use this information to create much needed small animal models for HCV. Using lentivirus-based cyclic repackaging schemes, we succeeded in identifying two tight junction proteins, claudin-1 and occludin, as critical HCV entry factors. We built on this finding by elucidating the human factors required for viral entry into mouse cells, and have now gone on to create the first genetically humanized mouse model supporting the entire HCV lifecycle. This achievement opens unprecedented opportunities to study HCV entry in vivo and to dissect it using the power of mouse genetics. We have also shown proof-of-concept for this animal model in passive and active vaccine strategies. In addition to advancing in vivo models, we are pursuing more biologically relevant cell culture systems for the virus. These include primary adult and fetal hepatocyte cultures and three-dimensional liver organoids. In this competing renewal, we employ our novel in vitro and in vivo systems to further understand the virus-host interactions required for HCV entry. We propose genetic and biophysical approaches to uncover the mechanisms of uptake. Our studies will, for the first time, define the composition and structure of the infecting particle, probe the interplay between virus and host- associated lipid metabolism factors, and map the molecular interaction network active during viral internalization.
描述(由申请者提供):这是2006年首次资助的“识别和表征进入丙型肝炎病毒所涉及的细胞因素”资助的竞争性续期。本实验室对丙型肝炎病毒基因表达和复制机制的研究已有二十多年的历史,但由于研究系统的不完善,我们对病毒进入的认识受到限制。我们和其他人克服了这一障碍,开发了研究丙型肝炎病毒体外进入的第一个平台-丙型肝炎病毒假颗粒(HCVpp)和完全感染性丙型肝炎病毒细胞培养系统(HCVcc)。随着这些新工具的出现,我们建议识别和表征丙型肝炎病毒感染所需的因素。这些研究的长期目标是利用这些信息来创建急需的丙型肝炎病毒小动物模型。使用基于慢病毒的循环重新包装方案,我们成功地确定了两个紧密连接蛋白,claudin-1和occludin,作为关键的丙型肝炎病毒进入因子。在这一发现的基础上,我们阐明了病毒进入小鼠细胞所需的人类因素,现在已经创造了第一个支持整个丙型肝炎病毒生命周期的遗传人化小鼠模型。这一成就为研究丙型肝炎病毒在体内的进入并利用小鼠遗传学的力量剖析它打开了前所未有的机会。我们还展示了被动和主动疫苗策略对该动物模型的概念验证。除了推进体内模型外,我们还在为病毒寻求更具生物学意义的细胞培养系统。这些包括成人和胎儿肝细胞的原代培养和三维肝脏器官培养。在这一竞争性更新中,我们使用我们的新型体外和体内系统来进一步了解丙型肝炎病毒进入所需的病毒-宿主相互作用。我们建议用遗传学和生物物理学的方法来揭示摄取的机制。我们的研究将首次确定感染颗粒的组成和结构,探索病毒和宿主相关脂代谢因子之间的相互作用,并绘制病毒内化过程中活跃的分子相互作用网络。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charles M Rice其他文献

The antiviral state of the cell: lessons from SARS-CoV-2
细胞的抗病毒状态:来自 SARS-CoV-2 的教训
  • DOI:
    10.1016/j.coi.2024.102426
  • 发表时间:
    2024-04-01
  • 期刊:
  • 影响因子:
    5.800
  • 作者:
    Jérémie Le Pen;Charles M Rice
  • 通讯作者:
    Charles M Rice
Locking out hepatitis C
锁定丙型肝炎
  • DOI:
    10.1038/nm0511-542
  • 发表时间:
    2011-05-05
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    Gisa Gerold;Charles M Rice
  • 通讯作者:
    Charles M Rice

Charles M Rice的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charles M Rice', 18)}}的其他基金

Employing viruses to unravel the functional significance of the m5C epitranscriptome
利用病毒揭示 m5C 表观转录组的功能意义
  • 批准号:
    10638533
  • 财政年份:
    2023
  • 资助金额:
    $ 51.39万
  • 项目类别:
Elucidating the mechanism by which ADAR1 prevents autoimmunity against self RNA
阐明 ADAR1 预防针对自身 RNA 的自身免疫的机制
  • 批准号:
    10667182
  • 财政年份:
    2023
  • 资助金额:
    $ 51.39万
  • 项目类别:
Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
一次跟踪一个分子 SARS-CoV-2:体外和体内单细胞中冠状病毒复制动态和宿主反应的时空研究
  • 批准号:
    10446423
  • 财政年份:
    2022
  • 资助金额:
    $ 51.39万
  • 项目类别:
A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
脑炎的清晰认识:用单细胞方法确定中枢神经系统黄病毒发病机制的基础
  • 批准号:
    10553697
  • 财政年份:
    2022
  • 资助金额:
    $ 51.39万
  • 项目类别:
Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
一次跟踪一个分子 SARS-CoV-2:体外和体内单细胞中冠状病毒复制动态和宿主反应的时空研究
  • 批准号:
    10570297
  • 财政年份:
    2022
  • 资助金额:
    $ 51.39万
  • 项目类别:
Scientific Core: BSL3 Virology and Animal Models
科学核心:BSL3 病毒学和动物模型
  • 批准号:
    10327991
  • 财政年份:
    2022
  • 资助金额:
    $ 51.39万
  • 项目类别:
Scientific Core: BSL3 Virology and Animal Models
科学核心:BSL3 病毒学和动物模型
  • 批准号:
    10841239
  • 财政年份:
    2022
  • 资助金额:
    $ 51.39万
  • 项目类别:
A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
脑炎的清晰认识:用单细胞方法确定中枢神经系统黄病毒发病机制的基础
  • 批准号:
    10446620
  • 财政年份:
    2022
  • 资助金额:
    $ 51.39万
  • 项目类别:
Virology Core
病毒学核心
  • 批准号:
    10513915
  • 财政年份:
    2022
  • 资助金额:
    $ 51.39万
  • 项目类别:
TMEM41B: a pan-flavivirus and pan-coronavirus host factor with antiviral potential
TMEM41B:具有抗病毒潜力的泛黄病毒和泛冠状病毒宿主因子
  • 批准号:
    10587597
  • 财政年份:
    2022
  • 资助金额:
    $ 51.39万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.39万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 51.39万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 51.39万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 51.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 51.39万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 51.39万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 51.39万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 51.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 51.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 51.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了